Sorrento Therapeutics Announces the Formation of Sorrento Therapeutics Mexico for Commercialization of COVI-STIX and Development of Sorrento’s Portfolio of COVID-19 Products in Mexico and Parts of Latin America
20 juil. 2021 15h29 HE
|
Sorrento Therapeutics, Inc.
Sorrento Therapeutics has established a Subsidiary Company in Mexico - Sorrento Therapeutics Mexico.Sorrento’s Mexican importer of record has received an initial importation permit from Mexico...